Literature DB >> 14577661

Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats.

Mauro A Montanaro1, Omar J Rimoldi, R Ariel Igal, Silvana Montenegro, María C Tarrés, Stella M Martínez, Rodolfo R Brenner.   

Abstract

Both diabetes mellitus type 1 and diabetes mellitus type 2 are widespread diseases that alter carbohydrate and lipid metabolism. e Stilmann-Salgado (eSS) rats are experimental animals that spontaneously evolve to a state similar to that of young people affected by non-insulin-dependent diabetes mellitus (NIDDM; type 2). Using 6-mon-old eSS rats that, according to the literature [Martinez, S.M., Tarrés, M.C., Montenegro, S., Milo, R., Picena, J.C., Figueroa, N., and Rabasa, S.R. (1988) Spontaneous Diabetes in eSS Rats, Acta Diabetol. Lat. 25, 303-313], had already developed insulin resistance, we investigated the changes evoked on delta9, delta6, and delta5 liver desaturases. The abundance of mRNA and enzymatic activities were measured, as well as the FA composition of liver microsomal lipids. Compared to control rats, the mRNA content and activity of SCD-1 (stearoyl CoA-desaturase, isoform of the delta9 desaturase) were significantly higher, whereas the mRNA and activities of delta6 and delta5 desaturases were not significantly modified. Correspondingly, the proportion of 18:1n-9 and the ratios of 18:1n-9/18:0 and 16:1/16:0 in lipids were significantly increased, whereas the proportion of 20:4n-6 was unaltered. These effects were found while glycemia was constant or increased. The results are completely opposite those described in insulin-dependent diabetes mellitus (type 1), in which a depression of all the desaturases is found. They suggest that in eSS rats, the activities of the desaturases were not modified by an insulin-resistance effect. Moreover, we suggest that the enhancement of SCD-1 activity might be considered as another typical sign of the NIDDM syndrome, because it has also been found in other animal models of NIDDM, for example, the ones evoked by the sucrose-rich diet and in the Zucker rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577661     DOI: 10.1007/s11745-003-1132-7

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  21 in total

1.  Separation of a protein factor necessary for the oxidative desaturation of fatty acids in the rat.

Authors:  A Catalá; A M Nervi; R R Brenner
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

2.  Effects of diabetes and insulin on hepatic delta6 desaturase gene expression.

Authors:  O J Rimoldi; G S Finarelli; R R Brenner
Journal:  Biochem Biophys Res Commun       Date:  2001-05-04       Impact factor: 3.575

3.  Spontaneous diabetes in eSS rats.

Authors:  S M Martínez; M C Tarrés; S Montenegro; R Milo; J C Picena; N Figueroa; S R Rabasa
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

4.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

5.  Lipid biosynthesis in adipose tissue during aging and in diabetes.

Authors:  A Gellhorn; W Benjamin
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

6.  Depression of microsomal desaturation of linoleic to gamma-linolenic acid in the alloxan-diabetic rat.

Authors:  O Mercuri; R O Peluffo; R R Brenner
Journal:  Biochim Biophys Acta       Date:  1966-04-04

7.  Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis.

Authors:  Sara Bassilian; Syed Ahmed; Shu K Lim; Laszlo G Boros; Catherine S Mao; W-N Paul Lee
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

Review 8.  Hormonal modulation of delta6 and delta5 desaturases: case of diabetes.

Authors:  Rodolfo R Brenner
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-02       Impact factor: 4.006

9.  Desaturase activities in rat model of insulin resistance induced by a sucrose-rich diet.

Authors:  Rodolfo R Brenner; Omar J Rimoldi; Yolanda B Lombardo; María S González; Ana M Bernasconi; Adriana Chicco; Juan C Basabe
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

10.  Early lipid alterations in spontaneously diabetic rats.

Authors:  I N de Gomez Dumm; S Montenegro; M C Tarrés; S M Martinez; R A Igal
Journal:  Acta Physiol Pharmacol Ther Latinoam       Date:  1998
View more
  5 in total

1.  The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver.

Authors:  Stella M Daniele; Silvana M Montenegro; María C Tarres; Juan C Picena; Stella M Martinez
Journal:  Diabetol Metab Syndr       Date:  2010-03-17       Impact factor: 3.320

2.  Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats).

Authors:  Alejandro Dain; Gaston Repossi; Gustavo T Diaz-Gerevini; Jairam Vanamala; Undurti N Das; Aldo R Eynard
Journal:  Lipids Health Dis       Date:  2016-11-25       Impact factor: 3.876

3.  Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case control study.

Authors:  Amani Alhazmi; Elizabeth Stojanovski; Manohar L Garg; Mark McEvoy
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

4.  Influence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats.

Authors:  Thomas Kopf; Hans-Ludwig Schaefer; Martin Troetzmueller; Harald Koefeler; Mark Broenstrup; Tatiana Konovalova; Gerd Schmitz
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

5.  Relationship between Body Mass Index, C-Peptide, and Delta-5-Desaturase Enzyme Activity Estimates in Adult Males.

Authors:  C Austin Pickens; Karen H Matsuo; Jenifer I Fenton
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.